What exactly is ozempic and who is it for? From diabetes to diet trends

In this episode of our podcast, we explore Ozempic and other GLP-1 agonist medications, tracing their journey from diabetes treatments to popular weight loss solutions. We'll examine their effectiveness, differences in dosages, and typical side effects. Our discussion will also cover their impact on diabetes management, specifically how Ozempic influences A1c levels. Joining us is Erin Phillips, a registered dietitian and diabetes expert from Seattle, WA, who specializes in diabetes and eating disorders. Erin advocates for weight-inclusive care and provides clinical consultations to healthcare professionals. Through our conversation, we aim to provide clarity on Ozempic's role in diabetes care and its implications for patients and providers alike. In This Episode We’ll Cover: What Ozempic is and why it's currently making headlines The initial purpose of Ozempic for diabetes management and its shift in use Erin's perspective on recommending Ozempic for people with diabetes Dosing disparities between weight loss and diabetes treatment, addressing concerns about potential side effects Outcomes observed in diabetes management with Ozempic and its typical impact on A1c levels Common side effects encountered in clinical practice and their potential impact on patients' quality of life + MUCH MORE! Our 2 simple asks to help us continue a free weekly show: Rate on iTunes or Spotify -  it literally takes two seconds Review - if you love the show, please leave a review on iTunes Erin’s Podcast: https://www.erinphillipsnutrition.com/podcast Informed consent for GLP-1s: https://sizeinclusivemedicine.org/glp1/ Are you living with diabetes or prediabetes and seeking support from a Registered Dietitian Nutritionist covered by insurance? Visit diabetesdigital.co to sign up for personalized, one-on-one nutrition counseling with one of our culturally aware and weight-inclusive Diabetes Dietitians today! Visit diabetesdigital.co/quiz to get started. For additional resources and shownotes, visit diabetesdigital.co/podcast.

There are no comments yet.

Please log in to write the first comment.